anti-Primate C-MYC antibody for Immunocytochemistry

Recommended C-MYC Antibody

Antigen
V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) Antibodies
  • MRTL
  • MYCC
  • bHLHe39
  • c-Myc
  • CMYC
  • c-myc
  • C-MYC
  • LOC100136746
  • RNCMYC
  • mMyc
  • AU016757
  • Myc2
  • Niard
  • Nird
  • MYC
  • cmyc
  • zc-myc
  • c-myc II
  • myc-B
  • myc2
  • CMyc
  • CG10798
  • D-Myc
  • DM
  • DMYc
  • Dm
  • Dmel\CG10798
  • Dmyc
  • EG:BACN5I9.1
  • anon-WO03040301.171
  • bHLHe57
  • c-MYC
  • d-myc
  • dMYC
  • dMyc
  • dMyc1
  • da
  • dm
  • dm/dMyc
  • dm/myc
  • dmyc
  • dmyc1
  • l(1)G0139
  • l(1)G0354
  • l(1)G0359
  • myc
  • MYC proto-oncogene, bHLH transcription factor
  • v-myc myelocytomatosis viral oncogene homolog
  • myelocytomatosis oncogene
  • MYC proto-oncogene, bHLH transcription factor a
  • MYC proto-oncogene, bHLH transcription factor L homeolog
  • v-myc myelocytomatosis viral oncogene homolog (avian)
  • CG10798 gene product from transcript CG10798-RB
  • MYC
  • LOC100136746
  • Myc
  • myca
  • myc.L
Epitope
AA 408-439, C-Term
150
94
52
50
42
42
24
21
17
16
15
15
14
11
9
9
5
5
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivity
Human, Primate
663
160
124
48
48
18
16
14
12
12
9
7
6
6
5
4
4
4
3
2
2
2
1
1
1
1
1
1
Host
Mouse
387
273
16
14
7
1
Clonality
Monoclonal
Conjugate
This C-MYC antibody is un-conjugated
40
40
34
17
17
15
9
7
7
7
7
7
7
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
2
2
2
2
2
2
2
1
1
1
Application
Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunofluorescence (IF)
424
199
179
172
157
110
107
63
53
37
19
15
15
14
14
10
3
2
1
Options
Catalog No. ABIN4285740
Contact our Customer Service for availability and price in your country.
Relevance Score ABIN Application Conjugate Host Isotype Epitope Clonality References Details
-13.0527115 ABIN4285746 FACS ICC IF Mouse IgG1 kappa AA 408-439, C-Term CT14-G4 0
-13.0527115 ABIN4285753 ELISA FACS ICC IF IHC (fro) WB Alexa Fluor 405 Mouse IgG1 kappa AA 408-439, C-Term CT14-G4 0
-13.0527115 ABIN4285754 ELISA FACS ICC IF IHC (fro) WB Alexa Fluor 488 Mouse IgG1 kappa AA 408-439, C-Term CT14-G4 0
-13.0527115 ABIN4285756 ELISA FACS ICC IF IHC (fro) WB Alexa Fluor 700 Mouse IgG1 kappa AA 408-439, C-Term CT14-G4 0
-13.0527115 ABIN4285759 ELISA FACS ICC IF IHC (fro) WB DyLight 650 Mouse IgG1 kappa AA 408-439, C-Term CT14-G4 0
-13.0527115 ABIN4285763 ELISA FACS ICC IF IHC (fro) WB DyLight 755 Mouse IgG1 kappa AA 408-439, C-Term CT14-G4 0
-13.0527115 ABIN4285766 ELISA FACS ICC IF IHC (fro) WB DyLight 550 Mouse IgG1 kappa AA 408-439, C-Term CT14-G4 0
-13.0527115 ABIN4285767 ELISA FACS ICC IF IHC (fro) WB DyLight 350 Mouse IgG1 kappa AA 408-439, C-Term CT14-G4 0
-13.0527115 ABIN4285768 ELISA FACS ICC IF IHC (fro) WB DyLight 405 Mouse IgG1 kappa AA 408-439, C-Term CT14-G4 0
-13.0527115 ABIN4285787 FACS ICC IF Alexa Fluor 405 Mouse IgG1 kappa AA 408-439, C-Term MYC699 0
-13.0527115 ABIN4285788 FACS ICC IF Alexa Fluor 488 Mouse IgG1 kappa AA 408-439, C-Term MYC699 0
-13.0527115 ABIN4285789 FACS ICC IF Alexa Fluor 647 Mouse IgG1 kappa AA 408-439, C-Term MYC699 0
-13.0527115 ABIN4285790 FACS ICC IF Alexa Fluor 700 Mouse IgG1 kappa AA 408-439, C-Term MYC699 0
-13.0527115 ABIN4285792 ICC IF Biotin Mouse IgG1 kappa AA 408-439, C-Term MYC699 0
-13.0527115 ABIN4285793 FACS ICC IF DyLight 650 Mouse IgG1 kappa AA 408-439, C-Term MYC699 0
-13.0527115 ABIN4285794 FACS ICC IF DyLight 680 Mouse IgG1 kappa AA 408-439, C-Term MYC699 0
-13.0527115 ABIN4285795 FACS ICC IF DyLight 488 Mouse IgG1 kappa AA 408-439, C-Term MYC699 0
-13.0527115 ABIN4285800 FACS ICC IF DyLight 550 Mouse IgG1 kappa AA 408-439, C-Term MYC699 0
-13.0527115 ABIN4285755 ELISA FACS ICC IF IHC (fro) WB Alexa Fluor 647 Mouse IgG1 kappa AA 408-439, C-Term CT14-G4 0
-13.0527115 ABIN4285758 ELISA ICC IF IHC (fro) WB Biotin Mouse IgG1 kappa AA 408-439, C-Term CT14-G4 0

General

Antigen V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) Antibodies
Epitope AA 408-439, C-Term
(150), (94), (52), (50), (42), (42), (24), (21), (17), (16), (15), (15), (14), (11), (9), (9), (5), (5), (3), (3), (2), (2), (2), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Reactivity Human, Primate
(663), (160), (124), (48), (48), (18), (16), (14), (12), (12), (9), (7), (6), (6), (5), (4), (4), (4), (3), (2), (2), (2), (1), (1), (1), (1), (1), (1)
Host Mouse
(387), (273), (16), (14), (7), (1)
Clonality (Clone)
Monoclonal   ( )
Conjugate This C-MYC antibody is un-conjugated
(40), (40), (34), (17), (17), (15), (9), (7), (7), (7), (7), (7), (7), (5), (5), (5), (5), (5), (5), (5), (5), (5), (5), (5), (5), (5), (4), (4), (4), (4), (4), (4), (4), (4), (4), (4), (4), (4), (4), (4), (4), (2), (2), (2), (2), (2), (2), (2), (1), (1), (1)
Application Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunofluorescence (IF)
(424), (199), (179), (172), (157), (110), (107), (63), (53), (37), (19), (15), (15), (14), (14), (10), (3), (2), (1)
Supplier

Product Details anti-C-MYC Antibody

Target Details C-MYC Application Details Handling Images
Specificity The c-Myc protein is a transcription factor, which is encoded by the c-Myc gene on human chromosome 8q24. c-Myc is commonly activated in a variety of tumor cells and plays an important role in cellular proliferation, differentiation, apoptosis and cell cycle progression. The phosphorylation of c-Myc has been investigated and previous studies have suggested a functional association between phosphorylation at Thr58/Ser62 by glycogen synthase kinase 3, cyclin dependent kinase, ERK2 and C-Jun N terminal Kinase (JNK) in cell proliferation and cell cycle regulation. Studies also have shown that c-Myc is essential for tumor cell development in vasculogenesis and angiogenesis that distribute blood throughout the cells, and which brought extensive attention in the development of new therapeutic approach for cancer treatment.
No Cross-Reactivity Mouse (Murine)
Purification Protein A or G purified
Immunogen A synthetic peptide, corresponding to aa 408-439 (AEEQKLISEEDLLRKRREQLKHKLEQL-RNSCA) from C-terminus of human c-myc, coupled to KLH
Clone MYC699
Isotype IgG1 kappa
Plasmids, Primers & others

Target Details C-MYC

Product Details anti-C-MYC Antibody Application Details Handling Images back to top
Antigen
Alternative Name C-Myc (MYC Antibody Abstract)
Background Gene Symbol: MYC
Gene ID 4609
UniProt P01106
Pathways p53 Signaling, Cell Division Cycle, Sensory Perception of Sound, Transition Metal Ion Homeostasis, Mitotic G1-G1/S Phases, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus

Application Details

Product Details anti-C-MYC Antibody Target Details C-MYC Handling Images back to top
Application Notes Flow Cytometry 0.5-1 μg/million cells, Immunocytochemistry/Immunofluorescence 1-2 μg/mLHuman Chromosome Location: 8q24.21 Mol. Weight of Antigen: 62-64 kDa
Comment

The antibodies are intended for use in vitro experiments only. Our antibodies have not been tested nor are recommended for use in vivo.

Restrictions For Research Use only

Handling

Product Details anti-C-MYC Antibody Target Details C-MYC Application Details Images back to top
Format Liquid
Buffer PBS with 0.05 % BSA.
Buffer contains: 0.05 % Sodium Azide
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Storage Comment Store at 4°C.